Overview

A Randomized Trial to Evaluate Efficacy and Safety of Intracavernosal Injection of Platelet-Rich Plasma Versus Phosphodiesterase Type-5 Inhibitors for Treatment of Erectile Dysfunction.

Status:
Active, not recruiting

Trial end date:
2025-01-25

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the efficacy and safety of intracavernosal injection of PRP in patients with moderate to severe ED.

Phase:

N/A

Details

Lead Sponsor:

Mansoura University